https://news.medxy.ai/zh/low-dose-rivaroxaban/Medxy AIzh2026-09-20T09:24:56-07:00重度慢性肾脏病合并高心血管风险患者低剂量利伐沙班的疗效与安全性：综合综述 https://news.medxy.ai/ja/low-dose-rivaroxaban-ckd/Medxy AIja2026-09-20T09:24:31-07:00高心血管リスクを伴う進行期慢性腎臓病における低用量リバーロキサバンの有効性と安全性：包括的レビュー https://news.medxy.ai/vi/75900-2/Medxy AIvi2026-09-20T09:24:05-07:00Hiệu quả và độ an toàn của rivaroxaban liều thấp ở bệnh nhân mắc bệnh thận mạn giai đoạn tiến triển và có nguy cơ tim mạch cao https://news.medxy.ai/efficacy-and-safety-of-low-dose-rivaroxaban-in-advanced-chronic-kidney-disease-with-high-cardiovascular-risk-a-comprehensive-review/Medxy AIen2026-09-20T09:23:39-07:00Efficacy and Safety of Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease with High Cardiovascular Risk: A Comprehensive Review https://news.medxy.ai/zh/pd-l1-pd-l2-b-cell-lymphoma-2/Medxy AIzh2026-09-20T09:22:45-07:00PD-L1与PD-L2在原发性纵隔大B细胞淋巴瘤中的不同作用：对免疫治疗的启示 https://news.medxy.ai/ja/pd-l1-pd-l2-roles/Medxy AIja2026-09-20T09:22:22-07:00原発性縦隔大細胞型B細胞リンパ腫におけるPD-L1とPD-L2の異なる役割：免疫治療への示唆 https://news.medxy.ai/vi/pd-l1-pd-l2-b-cell-lymphoma/Medxy AIvi2026-09-20T09:21:57-07:00Vai trò khác biệt của PD-L1 và PD-L2 trong u lympho tế bào B lớn nguyên phát trung thất: hàm ý cho miễn dịch trị liệu https://news.medxy.ai/distinct-roles-of-pd-l1-and-pd-l2-in-primary-mediastinal-large-b-cell-lymphoma-implications-for-immune-therapeutics/Medxy AIen2026-09-20T09:21:34-07:00Distinct Roles of PD-L1 and PD-L2 in Primary Mediastinal Large B-Cell Lymphoma: Implications for Immune Therapeutics https://news.medxy.ai/zh/neutrophil-driven-hemophilic-arthritis/Medxy AIzh2026-09-20T09:20:46-07:00中性粒细胞驱动的血友病性关节病干扰素病变：潜在新靶点的揭示 https://news.medxy.ai/ja/hemophilic-arthritis-research/Medxy AIja2026-09-20T09:20:25-07:00血友病性関節症における好中球駆動型インターフェロン病の解明：新たな治療標的 https://news.medxy.ai/vi/interferonopathy-treatment/Medxy AIvi2026-09-20T09:19:55-07:00Giải mã interferonopathy do bạch cầu trung tính trong bệnh khớp do máu khó đông: một đích điều trị mới https://news.medxy.ai/unraveling-neutrophil-driven-interferonopathy-in-hemophilic-arthropathy-a-new-therapeutic-target/Medxy AIen2026-09-20T09:19:28-07:00Unraveling Neutrophil-Driven Interferonopathy in Hemophilic Arthropathy: A New Therapeutic Target https://news.medxy.ai/zh/mycobacterium-massiliense/Medxy AIzh2026-09-20T09:18:45-07:00东亚特异性 Mycobacterium massiliense ST120：系统发育基因组学、临床影响与肺部疾病管理挑战 https://news.medxy.ai/ja/mycobacterium-massiliense-east-asia/Medxy AIja2026-09-20T09:18:23-07:00東アジアに特有な Mycobacterium massiliense ST120：系統ゲノム解析、臨床的影響、そして肺疾患管理の課題 https://news.medxy.ai/vi/75872-2/Medxy AIvi2026-09-20T09:17:59-07:00Những thách thức trong việc quản lý bệnh phổi do chủng *Mycobacterium massiliense* ST120 đặc thù tại Đông Á gây ra https://news.medxy.ai/east-asia-specific-mycobacterium-massiliense-st120-phylogenomics-clinical-impact-and-challenges-in-pulmonary-disease-management/Medxy AIen2026-09-20T09:17:36-07:00East Asia-Specific Mycobacterium massiliense ST120: Phylogenomics, Clinical Impact, and Challenges in Pulmonary Disease Management https://news.medxy.ai/zh/lynx1-phase3-trial/Medxy AIzh2026-09-20T09:17:01-07:00LYNX-1 Ⅲ期试验：0.75%酚妥拉明滴眼液改善暗光视觉障碍 https://news.medxy.ai/ja/fentolamine-eye-drops/Medxy AIja2026-09-20T09:16:34-07:00暗所視障害に対する0.75%フェントラミン点眼液：第3相LYNX-1試験の結果 https://news.medxy.ai/vi/phentolamine-eye-drops/Medxy AIvi2026-09-20T09:16:06-07:00LYNX-1 giai đoạn 3: dung dịch nhỏ mắt phentolamine cho rối loạn thị giác khi ánh sáng yếu https://news.medxy.ai/lynx-1-phase-3-trial-phentolamine-ophthalmic-solution-for-dim-light-vision-disturbances/Medxy AIen2026-09-20T09:15:40-07:00LYNX-1 Phase 3 Trial: Phentolamine Ophthalmic Solution for Dim Light Vision Disturbances https://news.medxy.ai/zh/linc01521-thyroid-cancer/Medxy AIzh2026-09-20T09:14:52-07:00LINC01521 在乳头状甲状腺癌中的作用：预后价值与分子机制探析 https://news.medxy.ai/ja/linc01521-thyroid-cancer-3/Medxy AIja2026-09-20T09:14:29-07:00乳頭状甲状腺癌におけるLINC01521の役割を解明する：予後予測能と分子機序 https://news.medxy.ai/vi/linc01521-thyroid-cancer-2/Medxy AIvi2026-09-20T09:14:02-07:00LINC01521 trong ung thư biểu mô nhú tuyến giáp: ý nghĩa tiên lượng và cơ chế phân tử https://news.medxy.ai/unraveling-the-role-of-linc01521-in-papillary-thyroid-carcinoma-prognostic-potential-and-molecular-mechanisms/Medxy AIen2026-09-20T09:13:36-07:00Unraveling the Role of LINC01521 in Papillary Thyroid Carcinoma: Prognostic Potential and Molecular Mechanisms https://news.medxy.ai/zh/xenotransplantation-liver-failure/Medxy AIzh2026-09-20T09:12:48-07:00急性肝衰竭中的异种移植：以基因修饰猪肝弥合供肝缺口 https://news.medxy.ai/ja/xenotransplantation-liver-failure-2/Medxy AIja2026-09-20T09:12:25-07:00急性肝不全における異種移植：遺伝子改変ブタ肝臓が切り開く臓器ギャップへの橋渡し https://news.medxy.ai/vi/xenotransplantation-liver/Medxy AIvi2026-09-20T09:11:56-07:00Ghép dị loài gan trong suy gan cấp: thu hẹp khoảng cách thiếu hụt tạng ghép bằng gan lợn biến đổi gen https://news.medxy.ai/xenotransplantation-in-acute-liver-failure-bridging-the-organ-gap-with-genetically-modified-porcine-livers/Medxy AIen2026-09-20T09:11:30-07:00Xenotransplantation in Acute Liver Failure: Bridging the Organ Gap with Genetically Modified Porcine Livers https://news.medxy.ai/zh/gut-vascular-barrier/Medxy AIzh2026-09-20T09:10:49-07:00肠-血管屏障失守：巨噬细胞功能障碍如何推动肝硬化中的细菌移位 https://news.medxy.ai/ja/liver-cirrhosis-barrier-breakdown/Medxy AIja2026-09-20T09:10:25-07:00肝硬変における腸管―血管バリア破綻を読み解く：マクロファージ機能障害が細菌トランスロケーションを駆動する https://news.medxy.ai/vi/vascular-barrier-breakdown/Medxy AIvi2026-09-20T09:09:56-07:00Khi hàng rào ruột-mạch máu bị phá vỡ: Rối loạn đại thực bào thúc đẩy chuyển vị vi khuẩn trong xơ gan https://news.medxy.ai/dissecting-gut-vascular-barrier-failures-macrophage-dysfunction-drives-bacterial-translocation-in-cirrhosis/Medxy AIen2026-09-20T09:09:31-07:00Dissecting Gut-Vascular Barrier Failures: Macrophage Dysfunction Drives Bacterial Translocation in Cirrhosis https://news.medxy.ai/zh/postmenopausal-estradiol-range/Medxy AIzh2026-09-20T09:08:49-07:00绝经后女性雌二醇参考范围实现统一：提升激素评估与风险预测准确性的突破 https://news.medxy.ai/ja/75832-2/Medxy AIja2026-09-20T09:08:26-07:00閉経後女性のエストラジオール基準範囲が統一されました https://news.medxy.ai/vi/estradiol-reference-women/Medxy AIvi2026-09-20T09:08:02-07:00Chuẩn hóa khoảng tham chiếu estradiol ở phụ nữ sau mãn kinh: Bước tiến cho đánh giá hormone chính xác và dự đoán nguy cơ https://news.medxy.ai/harmonizing-estradiol-reference-ranges-in-postmenopausal-women-a-breakthrough-for-accurate-hormone-assessment-and-risk-prediction/Medxy AIen2026-09-20T09:07:36-07:00Harmonizing Estradiol Reference Ranges in Postmenopausal Women: A Breakthrough for Accurate Hormone Assessment and Risk Prediction https://news.medxy.ai/zh/adam10-atrial-fibrillation/Medxy AIzh2026-09-20T09:06:55-07:00乳腺癌来源ADAM10：通过心房纤维化介导心房颤动的新机制 https://news.medxy.ai/ja/adam10-atrial-fibrillation-2/Medxy AIja2026-09-20T09:06:31-07:00乳がん由来ADAM10が心房細動を誘発する新機序：心房線維化を介した腫瘍―心臓連関 https://news.medxy.ai/vi/adam10-breast-cancer/Medxy AIvi2026-09-20T09:06:04-07:00ADAM10 có nguồn gốc từ ung thư vú: tác nhân mới làm trung gian rung nhĩ qua xơ hóa nhĩ https://news.medxy.ai/breast-cancer-derived-adam10-a-novel-mediator-of-atrial-fibrillation-through-atrial-fibrosis/Medxy AIen2026-09-20T09:05:38-07:00Breast Cancer-Derived ADAM10: A Novel Mediator of Atrial Fibrillation Through Atrial Fibrosis https://news.medxy.ai/zh/retina-octa-insights/Medxy AIzh2026-09-20T08:57:34-07:00视网膜OCTA：洞察脑小血管病与卒中后认知下降的新窗口 https://news.medxy.ai/ja/75805-2/Medxy AIja2026-09-20T08:57:09-07:00網膜OCTA：脳小血管病と脳卒中後の認知機能低下を解明する新たな窓 https://news.medxy.ai/vi/75804-2/Medxy AIvi2026-09-20T08:56:44-07:00OCTA võng mạc: Một góc nhìn mới về bệnh lý mạch máu nhỏ não và suy giảm nhận thức sau đột quỵ https://news.medxy.ai/retinal-octa-as-a-window-into-cerebral-small-vessel-disease-and-cognitive-decline-post-stroke/Medxy AIen2026-09-20T08:56:15-07:00Retinal OCTA as a Window into Cerebral Small Vessel Disease and Cognitive Decline Post-Stroke https://news.medxy.ai/zh/relapse-b-cell-leukemia/Medxy AIzh2026-09-20T08:55:33-07:00复发/难治性 B 细胞急性淋巴细胞白血病成人首次挽救治疗的预后因素及异基因造血干细胞移植作用 https://news.medxy.ai/ja/b-cell-leukemia-treatment/Medxy AIja2026-09-20T08:55:09-07:00ブリナツモマブ／イノツズマブ オゾガマイシンを用いた初回救援療法における再発／難治性B細胞急性リンパ性白血病成人患者の予後因子と同種造血幹細胞移植の役割 https://news.medxy.ai/vi/allo-hsct-prognosis-b-all/Medxy AIvi2026-09-20T08:54:42-07:00Yếu tố tiên lượng và vai trò của allo-HSCT trong điều trị cứu vãn bậc một ở người lớn mắc B-ALL tái phát/kháng trị điều trị bằng blinatumomab và inotuzumab ozogamicin https://news.medxy.ai/prognostic-factors-and-role-of-allo-hsct-in-first-salvage-therapy-for-adults-with-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia-treated-with-blinatumomab-and-inotuzumab-ozogamicin/Medxy AIen2026-09-20T08:54:17-07:00Prognostic Factors and Role of Allo-HSCT in First Salvage Therapy for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Blinatumomab and Inotuzumab Ozogamicin https://news.medxy.ai/zh/wean-failure-phenotypes-2/Medxy AIzh2026-09-20T08:51:31-07:00有创机械通气撤机失败的三种不同表型：来自WEAN SAFE队列的研究启示 https://news.medxy.ai/ja/wean-failure-phenotypes/Medxy AIja2026-09-20T08:51:11-07:00侵襲的人工呼吸離脱失敗にみられる3つの異なる表現型──WEAN SAFEコホートからの知見 https://news.medxy.ai/vi/wean-failure-types/Medxy AIvi2026-09-20T08:50:44-07:00Ba kiểu hình cai máy khác nhau ở bệnh nhân thất bại thở máy xâm nhập: phát hiện từ đoàn hệ WEAN SAFE https://news.medxy.ai/distinct-weaning-phenotypes-in-invasive-mechanical-ventilation-failures-insights-from-the-wean-safe-cohort/Medxy AIen2026-09-20T08:50:21-07:00Distinct Weaning Phenotypes in Invasive Mechanical Ventilation Failures: Insights from the WEAN SAFE Cohort https://news.medxy.ai/zh/75783-2/Medxy AIzh2026-09-20T08:49:45-07:00低剂量氯胺酮可减少ICU患者阿片类药物用量——一项针对机械通气患者的双盲随机试验结果 https://news.medxy.ai/ja/low-dose-ketamine-icu-opioids/Medxy AIja2026-09-20T08:49:23-07:00低用量ケタミンで ICU のオピオイド使用量を軽減　― 機械換気患者を対象とした二重盲検ランダム化試験からの知見 https://news.medxy.ai/vi/low-dose-ketamine-opioid-reduction/Medxy AIvi2026-09-20T08:49:00-07:00Ketamine liều thấp giúp giảm nhu cầu opioid ở bệnh nhân ICU thở máy: Những phát hiện từ một thử nghiệm ngẫu nhiên mù đôi https://news.medxy.ai/low-dose-ketamine-reduces-opioid-requirements-in-mechanically-ventilated-icu-patients-insights-from-a-double-blind-randomized-trial/Medxy AIen2026-09-20T08:48:38-07:00Low-Dose Ketamine Reduces Opioid Requirements in Mechanically Ventilated ICU Patients: Insights from a Double-Blind Randomized Trial https://news.medxy.ai/zh/icu-survivors-driving-2/Medxy AIzh2026-09-20T08:47:56-07:00ICU幸存者如何安全恢复驾驶：一项全面驾驶评估研究的启示 https://news.medxy.ai/ja/icu-survivors-driving/Medxy AIja2026-09-20T08:47:35-07:00ICU生存者の運転再開を可能にするために：包括的運転評価研究から得られた知見 https://news.medxy.ai/vi/driving-ability-survivors/Medxy AIvi2026-09-20T08:47:12-07:00Khả năng quay lại lái xe ở người sống sót sau ICU: phát hiện từ nghiên cứu đánh giá lái xe toàn diện https://news.medxy.ai/enabling-driving-resumption-in-icu-survivors-insights-from-a-comprehensive-driving-assessment-study/Medxy AIen2026-09-20T08:46:49-07:00Enabling Driving Resumption in ICU Survivors: Insights from a Comprehensive Driving Assessment Study https://news.medxy.ai/ja/75767-2/Medxy AIja2026-09-20T08:46:08-07:00救急診療における診断の卓越性と診断見落としの機会：実践と研究に関する重要なコンセンサスと提言 https://news.medxy.ai/vi/diagnostic-consensus/Medxy AIvi2026-09-20T08:45:29-07:00Đồng thuận mới về chẩn đoán xuất sắc và cơ hội chẩn đoán bị bỏ sót tại khoa Cấp cứu: Khuyến nghị cốt lõi cho thực hành và nghiên cứu https://news.medxy.ai/zh/emergency-diagnosis-consensus/Medxy AIzh2026-09-20T08:44:52-07:00急诊诊断卓越与遗漏诊断机会：实践与研究的关键共识建议 https://news.medxy.ai/defining-diagnostic-excellence-and-missed-diagnostic-opportunity-in-the-emergency-department-key-consensus-recommendations-for-practice-and-research/Medxy AIen2026-09-20T08:44:14-07:00Defining Diagnostic Excellence and Missed Diagnostic Opportunity in the Emergency Department: Key Consensus Recommendations for Practice and Research https://news.medxy.ai/dexmedetomidine-continuous-infusion-to-maintain-sedation-in-severely-agitated-adolescents-in-the-emergency-department-a-case-series-report/Medxy AIen2026-09-20T08:43:24-07:00Dexmedetomidine Continuous Infusion to Maintain Sedation in Severely Agitated Adolescents in the Emergency Department: A Case Series Report https://news.medxy.ai/zh/clinical-research-training/Medxy AIzh2026-09-20T08:42:44-07:00真实临床试验中的医学生研究培训新模式：以双导师与实践带教提升胜任力 https://news.medxy.ai/ja/clinical-research-education/Medxy AIja2026-09-20T08:42:24-07:00医学生の臨床研究教育を刷新する：真正なメンタリングと実践で育む能力向上 https://news.medxy.ai/vi/clinical-research-training-2/Medxy AIvi2026-09-20T08:41:58-07:00Đổi mới đào tạo nghiên cứu lâm sàng cho sinh viên y khoa bậc đại học: Nâng cao năng lực thông qua cố vấn chân thực và thực hành https://news.medxy.ai/innovative-clinical-research-training-for-medical-undergraduates-enhancing-competency-through-authentic-mentorship-and-practice/Medxy AIen2026-09-20T08:41:34-07:00Innovative Clinical Research Training for Medical Undergraduates: Enhancing Competency through Authentic Mentorship and Practice https://news.medxy.ai/enhancing-interprofessional-teamwork-in-icu-developing-entrustable-professional-activities-for-trainees-and-advanced-practice-providers/Medxy AIen2026-09-20T08:40:44-07:00Enhancing Interprofessional Teamwork in ICU: Developing Entrustable Professional Activities for Trainees and Advanced Practice Providers https://news.medxy.ai/ja/medical-ethics-ai/Medxy AIja2026-09-20T08:40:04-07:00AI時代の医療倫理と専門職性：American College of Physicians 2026年ポジションペーパーの要点 https://news.medxy.ai/vi/ethics-professionalism-ai/Medxy AIvi2026-09-20T08:39:24-07:00Đạo đức và tính chuyên nghiệp trong AI và thực hành y khoa: Hướng dẫn then chốt từ American College of Physicians (Bản tuyên bố lập trường 2026) https://news.medxy.ai/zh/ai-medical-ethics/Medxy AIzh2026-09-20T08:38:41-07:00AI与医疗实践中的伦理与专业精神：美国内科医师学会2026年立场文件要点 https://news.medxy.ai/ethics-and-professionalism-in-ai-and-medical-practice-key-guidance-from-the-american-college-of-physicians-2026-position-paper/Medxy AIen2026-09-20T08:38:04-07:00Ethics and Professionalism in AI and Medical Practice: Key Guidance from the American College of Physicians (2026 Position Paper) https://news.medxy.ai/ja/2025-va-dod-lipid-guidelines/Medxy AIja2026-09-20T08:37:07-07:002025年VA/DoD脂質管理ガイドライン要点：臨床医が押さえるべきポイント https://news.medxy.ai/vi/va-dod-lipid-guide/Medxy AIvi2026-09-20T08:36:22-07:00Tóm lược hướng dẫn quản lý lipid VA/DoD 2025: điều bác sĩ lâm sàng cần biết https://news.medxy.ai/zh/2025-lipid-guidelines/Medxy AIzh2026-09-20T08:35:38-07:002025年VA/DoD血脂管理指南速览：临床医生必须掌握的要点 https://news.medxy.ai/a-synopsis-of-the-2025-va-dod-lipid-management-guideline-what-clinicians-need-to-know/Medxy AIen2026-09-20T08:35:02-07:00A Synopsis of the 2025 VA/DoD Lipid Management Guideline: What Clinicians Need to Know https://news.medxy.ai/zh/75710-2/Medxy AIzh2026-09-20T08:33:54-07:00AL型淀粉样变性患者接受自体干细胞移植的当代疗效：一项为期十年多中心研究的启示 https://news.medxy.ai/ja/75708-2/Medxy AIja2026-09-20T08:33:30-07:00ALアミロイドーシスにおける自家幹細胞移植の現代的成績：10年にわたる多施設共同研究からの知見 https://news.medxy.ai/vi/75705-2/Medxy AIvi2026-09-20T08:33:06-07:00Kết quả hiện đại của phương pháp ghép tế bào gốc tự thân trong bệnh amyloidosis AL: Những hiểu biết từ nghiên cứu đa trung tâm kéo dài 10 năm https://news.medxy.ai/contemporary-outcomes-of-autologous-stem-cell-transplantation-in-al-amyloidosis-insights-from-a-decade-long-multicenter-study/Medxy AIen2026-09-20T08:32:44-07:00Contemporary Outcomes of Autologous Stem Cell Transplantation in AL Amyloidosis: Insights from a Decade-Long Multicenter Study https://news.medxy.ai/zh/hodgkin-lymphoma-age-treatment/Medxy AIzh2026-09-20T08:32:05-07:00经典型霍奇金淋巴瘤中年龄、蒽环类药物应用与死亡结局：来自大规模完整人群队列的启示 https://news.medxy.ai/vi/75696-2/Medxy AIvi2026-09-20T08:31:17-07:00Tuổi tác và Anthracycline ảnh hưởng đến tỷ lệ tử vong ở bệnh nhân u lympho Hodgkin https://news.medxy.ai/age-anthracycline-use-and-mortality-outcomes-in-classic-hodgkin-lymphoma-insights-from-a-large-complete-population-cohort/Medxy AIen2026-09-20T08:30:52-07:00Age, Anthracycline Use, and Mortality Outcomes in Classic Hodgkin Lymphoma: Insights from a Large Complete Population Cohort https://news.medxy.ai/zh/clag-m-vs-cpx-351-aml/Medxy AIzh2026-09-20T08:30:07-07:00CLAG-M 与 CPX-351 在医学上不适合强化治疗的 AML 成人中的比较：一项评估生存与缓解结局的随机Ⅱ期研究 https://news.medxy.ai/ja/75686-2/Medxy AIja2026-09-20T08:29:43-07:00急性骨髄性白血病（AML）の医学的に不適格な成人患者におけるCPX-351対CLAG-M https://news.medxy.ai/vi/cpx351-clagm-aml/Medxy AIvi2026-09-20T08:29:14-07:00CPX-351 và CLAG-M ở người lớn mắc AML không đủ điều kiện điều trị tích cực: Thử nghiệm ngẫu nhiên pha 2 đánh giá sống còn và đáp ứng https://news.medxy.ai/cpx-351-versus-clag-m-in-medically-unfit-adults-with-aml-a-phase-2-randomized-study-evaluating-survival-and-response-outcomes/Medxy AIen2026-09-20T08:28:47-07:00CPX-351 versus CLAG-M in Medically Unfit Adults with AML: A Phase 2 Randomized Study Evaluating Survival and Response Outcomes https://news.medxy.ai/zh/sickle-cell-blood-brain-barrier/Medxy AIzh2026-09-20T08:27:21-07:00从蛋白质组学看镰状细胞病中血脑屏障破坏的全身驱动因素 https://news.medxy.ai/ja/blood-brain-barrier-failure/Medxy AIja2026-09-20T08:26:47-07:00プロテオミクスで読み解く、鎌状赤血球症における血液脳関門破綻の全身性ドライバー https://news.medxy.ai/vi/blood-brain-barrier-sickle-cell/Medxy AIvi2026-09-20T08:26:22-07:00Giải mã các yếu tố toàn thân gây gián đoạn hàng rào máu – não trong bệnh hồng cầu hình liềm: Góc nhìn từ phân tích proteomic https://news.medxy.ai/unveiling-the-systemic-drivers-of-blood-brain-barrier-disruption-in-sickle-cell-disease-insights-from-proteomic-profiling/Medxy AIen2026-09-20T08:25:59-07:00Unveiling the Systemic Drivers of Blood-Brain Barrier Disruption in Sickle Cell Disease: Insights from Proteomic Profiling https://news.medxy.ai/zh/integrin-%ce%b1iib%ce%b23-deficiency/Medxy AIzh2026-09-20T08:25:16-07:00整合素 αIIbβ3 缺乏如何通过巨核细胞丝氨酸代谢紊乱削弱血小板生成 https://news.medxy.ai/ja/integrin-deficiency-platelet-formation/Medxy AIja2026-09-20T08:24:49-07:00インテグリン αIIbβ3 欠損は巨核球のセリン代謝異常を介して血小板形成を障害する https://news.medxy.ai/vi/75665-2/Medxy AIvi2026-09-20T08:24:20-07:00Sự thiếu hụt integrin αIIbβ3 làm suy giảm quá trình sản sinh tiểu cầu https://news.medxy.ai/integrin-deficiency-platelets/Medxy AIen2026-09-20T08:23:50-07:00Integrin αIIbβ3 Deficiency Impairs Platelet Formation Through Serine Metabolic Dysregulation in Megakaryocytes https://news.medxy.ai/zh/75658-2/Medxy AIzh2026-09-20T08:23:14-07:00医院转入率对风险调整后结局的影响：一项全国性回顾性队列研究的启示 https://news.medxy.ai/ja/75657-2/Medxy AIja2026-09-20T08:22:50-07:00リスク調整後転帰に対する院外からの転院受け入れ頻度の影響：全国規模のレトロスペクティブ・コホート研究からの知見 https://news.medxy.ai/vi/75656-2/Medxy AIvi2026-09-20T08:22:21-07:00Tác động của tỷ lệ bệnh nhân chuyển đến đối với các kết quả lâm sàng đã hiệu chỉnh theo nguy cơ https://news.medxy.ai/impact-of-hospital-transfer-in-prevalence-on-risk-adjusted-outcomes-insights-from-a-national-retrospective-cohort-study/Medxy AIen2026-09-20T08:21:53-07:00Impact of Hospital Transfer-In Prevalence on Risk-Adjusted Outcomes: Insights from a National Retrospective Cohort Study https://news.medxy.ai/zh/brain-natriuretic-peptide/Medxy AIzh2026-09-20T08:21:01-07:00肺动脉内膜剥脱术后脑钠肽水平：慢性血栓栓塞性肺动脉高压患者的预后生物标志物 https://news.medxy.ai/ja/cns-peptide-biomarker/Medxy AIja2026-09-20T08:20:40-07:00慢性血栓塞栓性肺高血圧症における肺動脈内膜剥離術後の予後バイオマーカーとしての脳性ナトリウム利尿ペプチド https://news.medxy.ai/vi/bnp-pulmonary-endarterectomy/Medxy AIvi2026-09-20T08:20:16-07:00BNP sau phẫu thuật pulmonary endarterectomy: Dấu ấn tiên lượng tử vong ở CTEPH https://news.medxy.ai/brain-natriuretic-peptide-levels-as-a-prognostic-biomarker-after-pulmonary-endarterectomy-in-chronic-thromboembolic-pulmonary-hypertension/Medxy AIen2026-09-20T08:19:53-07:00Brain Natriuretic Peptide Levels as a Prognostic Biomarker After Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension https://news.medxy.ai/zh/fibrosis-exercise-comparison/Medxy AIzh2026-09-20T08:19:12-07:00纤维化性间质性肺疾病中高强度间歇训练与中等强度持续训练的比较：随机对照试验的启示 https://news.medxy.ai/ja/75647-2/Medxy AIja2026-09-20T08:18:53-07:00線維化性間質性肺疾患における高強度インターバルトレーニングと中等強度持続トレーニングの比較：ランダム化比較試験からの示唆 https://news.medxy.ai/vi/hiit-vs-mit-fibrosis/Medxy AIvi2026-09-20T08:18:24-07:00Huấn luyện ngắt quãng cường độ cao so với huấn luyện liên tục cường độ vừa trong bệnh phổi kẽ xơ hóa: Góc nhìn từ một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/evaluating-high-intensity-interval-training-versus-moderate-intensity-continuous-training-in-fibrotic-interstitial-lung-disease-insights-from-a-randomized-controlled-trial/Medxy AIen2026-09-20T08:17:59-07:00Evaluating High Intensity Interval Training Versus Moderate Intensity Continuous Training in Fibrotic Interstitial Lung Disease: Insights from a Randomized Controlled Trial https://news.medxy.ai/zh/glp-1-sleep-apnea/Medxy AIzh2026-09-20T08:17:18-07:00GLP-1受体激动剂能否预防2型糖尿病中的阻塞性睡眠呼吸暂停？英国大型队列研究提示无明显获益 https://news.medxy.ai/ja/75642-2/Medxy AIja2026-09-20T08:16:54-07:00GLP-1受容体作動薬は2型糖尿病患者における閉塞性睡眠時無呼吸を予防できるか？ https://news.medxy.ai/vi/glp-1-receptor-agonists-sleep-apnea-prevention/Medxy AIvi2026-09-20T08:16:27-07:00Chất chủ vận thụ thể GLP-1 và phòng ngừa hội chứng ngưng thở khi ngủ do tắc nghẽn ở đái tháo đường típ 2: Bằng chứng từ một nghiên cứu đoàn hệ lớn tại Vương quốc Anh https://news.medxy.ai/glp-1-receptor-agonists-and-the-prevention-of-obstructive-sleep-apnea-in-type-2-diabetes-insights-from-a-large-uk-cohort-study/Medxy AIen2026-09-20T08:16:02-07:00GLP-1 Receptor Agonists and the Prevention of Obstructive Sleep Apnea in Type 2 Diabetes: Insights from a Large UK Cohort Study https://news.medxy.ai/zh/75638-2/Medxy AIzh2026-09-19T08:15:17-07:00韩国患者中 USH2A 相关视网膜色素变性的独特分子与临床特征 https://news.medxy.ai/ja/75637-2/Medxy AIja2026-09-19T08:14:54-07:00韓国人患者におけるUSH2A関連網膜色素変性症の特異的な分子・臨床プロファイル https://news.medxy.ai/vi/ush2a-retinopathy-korea/Medxy AIvi2026-09-19T08:14:33-07:00Viêm sắc tố võng mạc liên quan USH2A ở bệnh nhân Hàn Quốc: Hồ sơ phân tử và lâm sàng đặc trưng, gợi mở hướng điều trị nhắm đích https://news.medxy.ai/distinct-molecular-and-clinical-profiles-of-ush2a-associated-retinitis-pigmentosa-in-korean-patients-implications-for-targeted-therapy/Medxy AIen2026-09-19T08:14:10-07:00Distinct Molecular and Clinical Profiles of USH2A-Associated Retinitis Pigmentosa in Korean Patients: Implications for Targeted Therapy https://news.medxy.ai/zh/corneal-endothelial-cell-injection/Medxy AIzh2026-09-19T08:13:26-07:00培养的人角膜内皮细胞注射后囊样黄斑水肿：发生率、危险因素与视力预后 https://news.medxy.ai/ja/75628-2/Medxy AIja2026-09-19T08:12:59-07:00培養角膜内皮細胞注入後の嚢胞様黄斑浮腫：発生率、危険因子および視力予後 https://news.medxy.ai/vi/corneal-endothelial-pseudoguttata/Medxy AIvi2026-09-19T08:12:29-07:00Phù hoàng điểm dạng nang sau tiêm tế bào nội mô giác mạc người nuôi cấy: tỷ lệ mắc, yếu tố nguy cơ và tiên lượng thị giác https://news.medxy.ai/cystoid-macular-edema-following-cultured-human-corneal-endothelial-cell-injection-incidence-risk-factors-and-visual-prognosis/Medxy AIen2026-09-19T08:12:01-07:00Cystoid Macular Edema Following Cultured Human Corneal Endothelial Cell Injection: Incidence, Risk Factors, and Visual Prognosis https://news.medxy.ai/zh/lebanon-tonsillectomy-bleeding/Medxy AIzh2026-09-19T08:11:04-07:00扁桃体切除术后出血：发生率、危险因素及对成年患者的启示 https://news.medxy.ai/ja/post-tonsillectomy-bleeding-lebanon/Medxy AIja2026-09-19T08:10:41-07:00レバノンにおける扁桃摘出術後出血：成人患者の有病率・危険因子・臨床的意義 https://news.medxy.ai/vi/post-tonsillectomy-bleeding-lebanon-2/Medxy AIvi2026-09-19T08:10:19-07:00Xuất huyết sau cắt amidan ở Liban: Tỷ lệ hiện mắc, nguy cơ và ý nghĩa đối với người bệnh trưởng thành https://news.medxy.ai/post-tonsillectomy-hemorrhage-in-lebanon-prevalence-risks-and-implications-for-adult-patients/Medxy AIen2026-09-19T08:09:55-07:00Post-Tonsillectomy Hemorrhage in Lebanon: Prevalence, Risks, and Implications for Adult Patients https://news.medxy.ai/zh/beta-trace-protein-quantification/Medxy AIzh2026-09-19T08:09:11-07:00鼻棉中β-痕迹蛋白定量：用于垂体区肿瘤经鼻内镜术后脑脊液漏早期识别的新型诊断工具 https://news.medxy.ai/ja/beta-tp-spinal-fluid-leak/Medxy AIja2026-09-19T08:08:50-07:00鼻腔スポンジ中β-TP定量で術後髄液漏を早期診断：sellar tumor内視鏡手術後の新たな検査法 https://news.medxy.ai/vi/beta-trace-protein/Medxy AIvi2026-09-19T08:08:28-07:00Định lượng Beta-Trace Protein: Công cụ chẩn đoán mới giúp phát hiện sớm rò dịch não tủy sau phẫu thuật nội soi qua mũi cho u vùng yên https://news.medxy.ai/beta-trace-protein-quantification-a-novel-diagnostic-tool-for-early-detection-of-csf-leak-post-endoscopic-endonasal-sellar-tumor-surgery/Medxy AIen2026-09-19T08:08:07-07:00Beta-Trace Protein Quantification: A Novel Diagnostic Tool for Early Detection of CSF Leak Post-Endoscopic Endonasal Sellar Tumor Surgery https://news.medxy.ai/zh/75604-2/Medxy AIzh2026-09-19T08:07:25-07:00直肠癌手术中Colovac 装置与开放式转流性袢状回肠造口术：前瞻性荟萃分析 https://news.medxy.ai/ja/75603-2/Medxy AIja2026-09-19T08:06:57-07:00直腸癌手術におけるColovacデバイスと回腸ループストーマ造設術の比較 https://news.medxy.ai/vi/colovac-vs-ileostomy/Medxy AIvi2026-09-19T08:06:28-07:00Thiết bị Colovac so với mở hồi tràng quai chuyển lưu: Phân tích gộp tiến cứu trong phẫu thuật ung thư trực tràng https://news.medxy.ai/colovac-device-vs-diverting-loop-ileostomy-a-prospective-pooled-analysis-in-rectal-cancer-surgery/Medxy AIen2026-09-19T08:06:01-07:00Colovac Device vs Diverting Loop Ileostomy: A Prospective Pooled Analysis in Rectal Cancer Surgery https://news.medxy.ai/zh/liver-transplant-risks/Medxy AIzh2026-09-19T08:05:12-07:00肝移植的非工作时间风险：识别高危时段及其对患者结局的影响 https://news.medxy.ai/ja/75595-2/Medxy AIja2026-09-19T08:04:50-07:00肝移植における勤務時間外のリスクは、患者の転帰に影響を及ぼす https://news.medxy.ai/vi/75593-2/Medxy AIvi2026-09-19T08:04:27-07:00Rủi ro trong thời gian ngoài giờ hành chính khi thực hiện ghép gan ảnh hưởng đến kết quả điều trị của bệnh nhân https://news.medxy.ai/out-of-hours-liver-transplantation-identifying-high-risk-timeframes-and-implications-for-patient-outcomes/Medxy AIen2026-09-19T08:04:02-07:00Out-of-Hours Liver Transplantation: Identifying High-Risk Timeframes and Implications for Patient Outcomes https://news.medxy.ai/zh/hpv-tp53-prognosis/Medxy AIzh2026-09-19T08:03:16-07:00HPV 与 TP53 分子分型揭示早期外阴鳞状细胞癌的预后差异 https://news.medxy.ai/ja/vulvar-cancer-stratification/Medxy AIja2026-09-19T08:02:55-07:00外陰扁平上皮癌早期症例における分子層別化：HPVとTP53の予後への影響 https://news.medxy.ai/vi/75583-2/Medxy AIvi2026-09-19T08:02:30-07:00Phân loại phân tử dựa trên HPV và TP53 cho thấy sự khác biệt về tiên lượng ở ung thư biểu mô tế bào vảy âm hộ giai đoạn sớm https://news.medxy.ai/molecular-stratification-of-early-stage-vulvar-squamous-cell-carcinoma-prognostic-impact-of-hpv-and-tp53-status/Medxy AIen2026-09-19T08:02:07-07:00Molecular Stratification of Early-Stage Vulvar Squamous Cell Carcinoma: Prognostic Impact of HPV and TP53 Status https://news.medxy.ai/zh/rhd-positive-blood/Medxy AIzh2026-09-19T08:01:19-07:00创伤患者中 RhD 阳性全血的再评估：两项随机试验后的伦理与临床启示 https://news.medxy.ai/ja/75574-2/Medxy AIja2026-09-19T08:00:56-07:00外傷患者におけるRhD陽性全血の再評価：2つの無作為化試験が示唆する倫理的および臨床的意義 https://news.medxy.ai/vi/rhd-blood-transfusion/Medxy AIvi2026-09-19T08:00:28-07:00Xem xét lại việc sử dụng máu toàn phần RhD dương tính ở bệnh nhân chấn thương còn khả năng sinh sản: hàm ý đạo đức và lâm sàng sau hai thử nghiệm ngẫu nhiên https://news.medxy.ai/reevaluating-rhd-positive-whole-blood-use-in-trauma-patients-with-reproductive-potential-ethical-and-clinical-implications-post-two-randomized-trials/Medxy AIen2026-09-19T08:00:04-07:00Reevaluating RhD-Positive Whole Blood Use in Trauma Patients with Reproductive Potential: Ethical and Clinical Implications Post-Two Randomized Trials https://news.medxy.ai/zh/perimenopause-hormone-treatment/Medxy AIzh2026-09-19T07:59:24-07:00围绝经期激素治疗怎么选：临床医生实用工具包 https://news.medxy.ai/ja/menopause-hormone-therapy-guide/Medxy AIja2026-09-19T07:59:06-07:00更年期移行期のホルモン療法をどう使い分けるか：臨床医のための実践ガイド https://news.medxy.ai/navigating-hormonal-therapies-for-perimenopause-a-practical-clinicians-toolkit/Medxy AIen2026-09-19T07:58:25-07:00Navigating Hormonal Therapies for Perimenopause: A Practical Clinician’s Toolkit https://news.medxy.ai/zh/vps13d-lipid-metabolism/Medxy AIzh2026-09-19T07:57:49-07:00VPS13D：酒精相关性脂肪性肝炎中细胞器接触位点与脂质代谢的关键调控因子 https://news.medxy.ai/ja/vps13d-alcoholic-hepatitis/Medxy AIja2026-09-19T07:57:22-07:00VPS13D：アルコール関連脂肪肝炎におけるオルガネラ接触部位と脂質代謝を制御する重要因子 https://news.medxy.ai/vi/vps13d-lipid-metabolism-2/Medxy AIvi2026-09-19T07:56:58-07:00VPS13D: Bộ điều hòa then chốt của các vị trí tiếp xúc bào quan và chuyển hóa lipid trong viêm gan nhiễm mỡ liên quan đến rượu https://news.medxy.ai/vps13d-a-crucial-regulator-of-organelle-contact-sites-and-lipid-metabolism-in-alcohol-associated-steatohepatitis/Medxy AIen2026-09-19T07:56:34-07:00VPS13D: A Crucial Regulator of Organelle Contact Sites and Lipid Metabolism in Alcohol-Associated Steatohepatitis https://news.medxy.ai/zh/tl1a-il22-crohn-treatment/Medxy AIzh2026-09-19T07:55:49-07:00揭示TL1A-LTα1β2/IL-22轴：克罗恩病伴肛周瘘管性疾病的新型治疗靶点 https://news.medxy.ai/ja/crohns-disease-treatment/Medxy AIja2026-09-19T07:55:26-07:00クローン病の肛門周囲瘻孔形成性疾患における新規治療標的：TL1A-LTα1β2/IL-22軸の全貌 https://news.medxy.ai/vi/tl1a-lt1b2-il22-crohns-treatment/Medxy AIvi2026-09-19T07:55:03-07:00Khám phá trục TL1A-LTα1β2/IL-22: Đích điều trị mới trong bệnh Crohn kèm bệnh rò quanh hậu môn https://news.medxy.ai/tl1a-il22-crohns-target/Medxy AIen2026-09-19T07:54:34-07:00Unveiling the TL1A-LTα1β2/IL-22 Axis: A New Therapeutic Target in Crohn’s Disease with Perianal Fistulising Disease https://news.medxy.ai/zh/safety-recurrence-balance/Medxy AIzh2026-09-19T07:53:50-07:00安全性与复发风险如何平衡：大型结直肠息肉冷圈套与热圈套切除术比较 https://news.medxy.ai/ja/safety-vs-recurrence/Medxy AIja2026-09-19T07:53:24-07:00安全性と再発リスクの両立をどう見るか：大腸大型ポリープに対するコールドスネア vs ホットスネア切除 https://news.medxy.ai/vi/large-colon-polyp-removal/Medxy AIvi2026-09-19T07:52:52-07:00Cân bằng giữa độ an toàn và nguy cơ tái phát: Cắt polyp đại trực tràng lớn bằng cold snare hay hot snare https://news.medxy.ai/balancing-safety-and-recurrence-cold-vs-hot-snare-resection-of-large-colorectal-polyps/Medxy AIen2026-09-19T07:52:24-07:00Balancing Safety and Recurrence: Cold vs Hot Snare Resection of Large Colorectal Polyps https://news.medxy.ai/zh/artery-spin-labeling/Medxy AIzh2026-09-19T07:51:38-07:00动脉自旋标记血流动力学指标可预测11年内认知下降与脑小血管病进展 https://news.medxy.ai/ja/75529-2/Medxy AIja2026-09-19T07:51:17-07:00動脈スピンラベリング法による血行動態評価は、11年以内の認知機能低下および脳小血管病を予測し得る https://news.medxy.ai/vi/75528-2/Medxy AIvi2026-09-19T07:50:53-07:00Các chỉ số huyết động học từ kỹ thuật Arterial Spin Labeling dự báo sự suy giảm nhận thức và tiến triển của bệnh lý mạch máu nhỏ trong suốt 11 năm https://news.medxy.ai/arterial-spin-labeling-hemodynamic-metrics-predict-cognitive-decline-and-small-vessel-disease-progression-over-11-years/Medxy AIen2026-09-19T07:50:28-07:00Arterial Spin Labeling Hemodynamic Metrics Predict Cognitive Decline and Small Vessel Disease Progression Over 11 Years https://news.medxy.ai/zh/75520-2/Medxy AIzh2026-09-19T07:49:46-07:00急性缺血性脑卒中后的住院康复与主要不良心血管事件：临床意义与证据整合 https://news.medxy.ai/ja/stroke-rehabilitation-2/Medxy AIja2026-09-19T07:49:22-07:00急性虚血性脳卒中後の入院リハビリテーションと主要有害心血管イベント：臨床的意義とエビデンスの統合 https://news.medxy.ai/inpatient-rehabilitation-and-major-adverse-cardiovascular-events-after-ischemic-stroke-clinical-implications-and-evidence-synthesis/Medxy AIen2026-09-19T07:48:25-07:00Inpatient Rehabilitation and Major Adverse Cardiovascular Events After Ischemic Stroke: Clinical Implications and Evidence Synthesis https://news.medxy.ai/zh/us-ischemic-stroke-transfer/Medxy AIzh2026-09-19T07:47:31-07:00美国缺血性卒中紧急院际转运：2016—2022年趋势与启示 https://news.medxy.ai/ja/us-ischemic-stroke-transfers/Medxy AIja2026-09-19T07:47:00-07:00米国の虚血性卒中における緊急施設間転送：2016〜2022年の動向と示唆 https://news.medxy.ai/vi/stroke-transfer-trends/Medxy AIvi2026-09-19T07:46:33-07:00Chuyển viện khẩn cấp liên cơ sở ở bệnh nhân đột quỵ thiếu máu cục bộ tại Hoa Kỳ: Xu hướng và ý nghĩa từ 2016 đến 2022 https://news.medxy.ai/emergent-interfacility-transfers-for-ischemic-stroke-in-the-u-s-patterns-and-implications-from-2016-to-2022/Medxy AIen2026-09-19T07:46:07-07:00Emergent Interfacility Transfers for Ischemic Stroke in the U.S.: Patterns and Implications from 2016 to 2022 https://news.medxy.ai/vi/easd-2026-guidelines/Medxy AIvi2026-09-19T07:43:40-07:00Hướng dẫn EASD 2026 mới: Chăm sóc thực tiễn, dựa trên bằng chứng cho diabetes distress ở người trưởng thành mắc đái tháo đường týp 1 và týp 2 https://news.medxy.ai/zh/easd-2026-diabetes-guidelines/Medxy AIzh2026-09-19T07:43:05-07:002026年EASD新指南：1型和2型糖尿病成人糖尿病困扰的实用循证管理 https://news.medxy.ai/new-2026-easd-guideline-practical-evidence-based-care-for-diabetes-distress-in-adults-with-type-1-and-type-2-diabetes/Medxy AIen2026-09-19T07:42:28-07:00New 2026 EASD Guideline: Practical, Evidence-Based Care for Diabetes Distress in Adults with Type 1 and Type 2 Diabetes https://news.medxy.ai/zh/steroid-analysis-ai/Medxy AIzh2026-09-19T07:41:28-07:00机器学习赋能类固醇谱分析：先天性肾上腺类固醇生成障碍的快速诊断新策略 https://news.medxy.ai/ja/steroid-profiling-diagnosis/Medxy AIja2026-09-19T07:41:07-07:00機械学習で精度を高めたステロイドプロファイリングによる先天性副腎ステロイド合成障害の迅速診断 https://news.medxy.ai/vi/steroid-biosynthesis-diagnostics/Medxy AIvi2026-09-19T07:40:36-07:00Hồ sơ steroid tăng cường bởi Machine Learning giúp chẩn đoán nhanh các rối loạn sinh tổng hợp steroid tuyến thượng thận bẩm sinh https://news.medxy.ai/machine-learning-enhanced-steroid-profiling-for-rapid-diagnosis-of-congenital-adrenal-steroidogenesis-disorders/Medxy AIen2026-09-19T07:40:10-07:00Machine Learning-enhanced Steroid Profiling for Rapid Diagnosis of Congenital Adrenal Steroidogenesis Disorders https://news.medxy.ai/ja/testosterone-women-children/Medxy AIja2026-09-19T07:39:25-07:00女性・小児のテストステロン基準範囲に新たな合意　2024年PCOS Challenge–CDCステークホルダー会議の成果 https://news.medxy.ai/vi/75458-2/Medxy AIvi2026-09-19T07:38:42-07:00Đạt được sự đồng thuận mới về các khoảng tham chiếu testosterone cho phụ nữ và trẻ em https://news.medxy.ai/zh/testosterone-reference-2024/Medxy AIzh2026-09-19T07:38:00-07:00女性与儿童睾酮参考区间迎来新共识：2024年PCOS Challenge–CDC利益相关方会议成果 https://news.medxy.ai/testosterone-reference-ranges/Medxy AIen2026-09-19T07:37:22-07:00New Consensus on Testosterone Reference Ranges for Females and Children: Outcomes of the 2024 PCOS Challenge–CDC Stakeholder Meeting https://news.medxy.ai/ja/weight-loss-uric-acid-management/Medxy AIja2026-09-19T07:35:54-07:00高尿酸血症男性の減量と尿酸管理：エネルギー制限DASH食・炭水化物制限食・低プリン体食の比較 https://news.medxy.ai/vi/dash-diet-weight-loss/Medxy AIvi2026-09-19T07:35:24-07:00So sánh chế độ ăn DASH hạn chế calo, chế độ ăn hạn chế carbohydrate và chế độ ăn ít purin trong giảm cân và kiểm soát urat huyết thanh ở nam giới tăng axit uric máu https://news.medxy.ai/zh/reducing-cardiogenic-shock-mortality-2/Medxy AIzh2026-09-19T07:34:13-07:00心源性休克死亡率如何降低：医院救治能力与转运策略的影响 https://news.medxy.ai/ja/reducing-cardiogenic-shock-mortality/Medxy AIja2026-09-19T07:33:52-07:00心原性ショックの死亡率を下げるには：病院機能と搬送戦略の影響 https://news.medxy.ai/vi/75446-2/Medxy AIvi2026-09-19T07:33:26-07:00Cách giảm tỷ lệ tử vong do sốc tim: Tác động của năng lực điều trị tại bệnh viện và các chiến lược vận chuyển https://news.medxy.ai/reducing-mortality-in-cardiogenic-shock-the-impact-of-hospital-capability-and-transfer-strategies/Medxy AIen2026-09-19T07:33:01-07:00Reducing Mortality in Cardiogenic Shock: The Impact of Hospital Capability and Transfer Strategies https://news.medxy.ai/zh/car-t-cardiovascular-risk-elderly/Medxy AIzh2026-09-19T07:32:17-07:00CAR-T治疗在老年人中的心血管风险：来自美国 Medicare 数据的启示 https://news.medxy.ai/ja/car-t-cardiovascular-risk/Medxy AIja2026-09-19T07:31:57-07:00高齢者におけるCAR-T療法の心血管リスク：米国Medicareデータが示す知見 https://news.medxy.ai/vi/car-t-cardiac-risk-elderly/Medxy AIvi2026-09-19T07:31:33-07:00Nguy cơ tim mạch của liệu pháp CAR-T ở người cao tuổi: phân tích từ dữ liệu Medicare Hoa Kỳ https://news.medxy.ai/cardiovascular-risks-of-car-t-therapy-in-older-adults-insights-from-us-medicare-data/Medxy AIen2026-09-19T07:31:06-07:00Cardiovascular Risks of CAR-T Therapy in Older Adults: Insights from US Medicare Data https://news.medxy.ai/zh/proteomics-metabolomics-cardiotoxicity/Medxy AIzh2026-09-19T07:30:21-07:00蛋白质组学与代谢组学揭示乳腺癌心脏毒性治疗相关心脏重构的新机制 https://news.medxy.ai/ja/cardiotoxicity-breast-cancer/Medxy AIja2026-09-19T07:30:02-07:00心毒性治療を受ける乳癌患者の心リモデリングを読み解くプロテオミクス・メタボロミクス解析 https://news.medxy.ai/vi/proteomics-metabolomics-heart/Medxy AIvi2026-09-19T07:29:37-07:00Proteomics và metabolomics hé lộ cơ chế tái cấu trúc tim ở bệnh nhân ung thư vú điều trị có nguy cơ độc tính trên tim https://news.medxy.ai/proteomic-and-metabolomic-insights-into-cardiac-remodeling-in-breast-cancer-patients-undergoing-cardiotoxic-therapy/Medxy AIen2026-09-19T07:29:15-07:00Proteomic and Metabolomic Insights into Cardiac Remodeling in Breast Cancer Patients Undergoing Cardiotoxic Therapy https://news.medxy.ai/zh/intravascular-imaging-pci/Medxy AIzh2026-09-19T07:28:33-07:00血管内影像指导PCI：更新荟萃分析证实可改善心血管结局 https://news.medxy.ai/ja/pci-optimization/Medxy AIja2026-09-19T07:28:11-07:00冠動脈内イメージングでPCIはさらに最適化できるか？ 28件のRCTメタ解析が示す心血管アウトカム改善 https://news.medxy.ai/vi/75431-2/Medxy AIvi2026-09-19T07:27:43-07:00Can thiệp mạch vành qua da (PCI) dưới hướng dẫn của hình ảnh nội mạch giúp cải thiện các kết cục tim mạch https://news.medxy.ai/intracoronary-imaging-guided-pci-updated-meta-analysis-validates-cardiovascular-outcome-benefits/Medxy AIen2026-09-19T07:27:18-07:00Intracoronary Imaging-Guided PCI: Updated Meta-Analysis Validates Cardiovascular Outcome Benefits https://news.medxy.ai/zh/rbm20-mitochondria-dysfunction/Medxy AIzh2026-09-19T07:26:34-07:00RBM20 相关扩张型心肌病的线粒体功能障碍：失调核糖核蛋白颗粒的关键作用 https://news.medxy.ai/ja/75427-2/Medxy AIja2026-09-19T07:26:12-07:00RBM20関連拡張型心筋症におけるミトコンドリア機能障害 https://news.medxy.ai/vi/75426-2/Medxy AIvi2026-09-19T07:25:49-07:00Rối loạn chức năng ty thể trong bệnh cơ tim giãn liên quan đến RBM20 https://news.medxy.ai/unraveling-mitochondrial-dysfunction-in-rbm20-related-dilated-cardiomyopathy-the-role-of-dysregulated-ribonucleoprotein-granules/Medxy AIen2026-09-19T07:25:24-07:00Unraveling Mitochondrial Dysfunction in RBM20-Related Dilated Cardiomyopathy: The Role of Dysregulated Ribonucleoprotein Granules https://news.medxy.ai/zh/ccnd1-pdk4-axis/Medxy AIzh2026-09-19T07:24:36-07:00靶向 CCND1-PDK4 轴促进修复型巨噬细胞表型并减轻心肌梗死后心脏重构 https://news.medxy.ai/ja/ccnd1-pdk4-cardiac-remodeling/Medxy AIja2026-09-19T07:24:12-07:00CCND1-PDK4軸を標的とした修復型マクロファージ誘導による心筋梗塞後心リモデリング抑制 https://news.medxy.ai/vi/ccnd1-pdk4-macrophage/Medxy AIvi2026-09-19T07:23:44-07:00Nhắm trục CCND1-PDK4 để thúc đẩy kiểu hình đại thực bào có tính sửa chữa và hạn chế tái cấu trúc tim sau nhồi máu cơ tim https://news.medxy.ai/targeting-the-ccnd1-pdk4-axis-to-promote-reparative-macrophage-phenotype-and-mitigate-post-myocardial-infarction-cardiac-remodeling/Medxy AIen2026-09-19T07:23:18-07:00Targeting the CCND1-PDK4 Axis to Promote Reparative Macrophage Phenotype and Mitigate Post-Myocardial Infarction Cardiac Remodeling